Literature DB >> 18281281

Evidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms.

Sarah J Goodger1, Christopher J Robinson, Kevin J Murphy, Nijole Gasiunas, Nicholas J Harmer, Tom L Blundell, David A Pye, John T Gallagher.   

Abstract

Heparin-like saccharides play an essential role in binding to both fibroblast growth factors (FGF) and their receptors at the cell surface. In this study we prepared a series of heparin oligosaccharides according to their size and sulfation level. We then investigated their affinity for FGF2 and their ability to support FGF2 mitogenesis of heparan sulfate-deficient cells expressing FGFR1c. Tetra- and hexasaccharides bound FGF2, but failed to dimerize the growth factor. Nevertheless, these saccharides promoted FGF2-mediated cell growth. Furthermore, whereas enzymatic removal of the non-reducing end 2-O-sulfate group had little effect on the 1:1 interaction with FGF2, it eliminated the mitogenic activity of these saccharides. This evidence supports the symmetric two-end model of ternary complex formation. In contrast, even at very low concentrations, octasaccharide and larger heparin fragments conferred a potent mitogenic activity that was independent of terminal 2-O-sulfation. This correlated with the ability to dimerize FGF2 in an apparently cooperative manner. This data suggests that potent mitogenic signaling results from heparin-mediated trans-dimerization of FGF2, consistent with the asymmetric model of ternary complex formation. We propose that, depending on saccharide structure, there are different architectures and modes of ternary complex assembly that differ in stability and/or efficiency of transmembrane signaling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18281281     DOI: 10.1074/jbc.M704531200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Syndecan-4 proteoliposomes enhance fibroblast growth factor-2 (FGF-2)-induced proliferation, migration, and neovascularization of ischemic muscle.

Authors:  Eugene Jang; Hassan Albadawi; Michael T Watkins; Elazer R Edelman; Aaron B Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

2.  Preactivation-based, one-pot combinatorial synthesis of heparin-like hexasaccharides for the analysis of heparin-protein interactions.

Authors:  Zhen Wang; Yongmei Xu; Bo Yang; Gopinath Tiruchinapally; Bin Sun; Renpeng Liu; Steven Dulaney; Jian Liu; Xuefei Huang
Journal:  Chemistry       Date:  2010-07-26       Impact factor: 5.236

3.  Effect of heparin oligomer chain length on the activation of valvular interstitial cells.

Authors:  Sara Pedron; Andrea M Kasko; Carmen Peinado; Kristi S Anseth
Journal:  Biomacromolecules       Date:  2010-06-14       Impact factor: 6.988

4.  Heparan sulfate domain organization and sulfation modulate FGF-induced cell signaling.

Authors:  Nadja Jastrebova; Maarten Vanwildemeersch; Ulf Lindahl; Dorothe Spillmann
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

5.  Extended N-sulfated domains reside at the nonreducing end of heparan sulfate chains.

Authors:  Gregory O Staples; Xiaofeng Shi; Joseph Zaia
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

Review 6.  Matrix regulators in neural stem cell functions.

Authors:  Anna Wade; Andrew McKinney; Joanna J Phillips
Journal:  Biochim Biophys Acta       Date:  2014-01-18

7.  Heparan sulfate acts as a bone morphogenetic protein coreceptor by facilitating ligand-induced receptor hetero-oligomerization.

Authors:  Wan-Jong Kuo; Michelle A Digman; Arthur D Lander
Journal:  Mol Biol Cell       Date:  2010-09-22       Impact factor: 4.138

8.  Synthetic heparan sulfate oligosaccharides inhibit endothelial cell functions essential for angiogenesis.

Authors:  Claire L Cole; Steen U Hansen; Marek Baráth; Graham Rushton; John M Gardiner; Egle Avizienyte; Gordon C Jayson
Journal:  PLoS One       Date:  2010-07-21       Impact factor: 3.240

Review 9.  Proteoglycans and their roles in brain cancer.

Authors:  Anna Wade; Aaron E Robinson; Jane R Engler; Claudia Petritsch; C David James; Joanna J Phillips
Journal:  FEBS J       Date:  2013-02-06       Impact factor: 5.542

10.  The role of tenascin-C in tissue injury and tumorigenesis.

Authors:  Kim S Midwood; Gertraud Orend
Journal:  J Cell Commun Signal       Date:  2009-10-17       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.